Healio

Exacerbations hasten emphysema progression in former smokers with COPD

Please provide your email address to receive an email when new articles are posted on . “We found a stepwise greater loss of lung density with increasing exacerbation frequency, predominantly in ...
Medscape

New Biologic Offers Hope for Hard-to-Treat COPD Patients

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...
Healio

Speech features change during onset, peak of COPD exacerbation

Please provide your email address to receive an email when new articles are posted on . Minimum pitch in the morning was significantly higher at exacerbation onset and peak vs. baseline. In the ...
Medscape

Sclerostin Predicts Exacerbations in COPD Patients

Lower levels of serum sclerostin (SOST) were significantly associated with increased risk of lung exacerbations and hospitalizations in adults with chronic obstructive pulmonary disease (COPD), based ...

Strados Labs Announces Study Evaluating Remote Lung Sound Monitoring to Predict COPD Exacerbations

The SHORE study, in collaboration with Jefferson Health, will assess the feasibility of home-based, continuous monitoring of cough and lung sounds including wheeze and rhonchi following COPD ...
Hosted on MSN

COPD Flare-up? Here's How to Breathe Easier and When to Call a Doctor

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage to the airways. It typically refers to emphysema and chronic bronchitis.
Becker's Hospital Review

Poor sleep quality linked to COPD exacerbation

Poor quality of sleep was found to have a strong association with symptomatic exacerbations of chronic obstructive pulmonary disease, according to a recent Canadian study presented at the 2016 ...
PharmiWeb

NICE issued final draft guidance recommending dupilumab for eligible COPD patients, positioning it to become the first NHS-recommended biologic for COPD tr…

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...
MedPage Today

Timing of CV Events After COPD Exacerbations

—Theses investigators found an increased risk for both individual and composite cardiovascular events following exacerbations of COPD, with sustained risk after 1 year regardless of severity. Reviewed ...
The American Journal of Managed Care

Dupilumab Cuts COPD Exacerbations by 30% in Phase 3 Trial

Dupilumab is the first biologic to significantly improve lung function in chronic obstructive pulmonary disease (COPD), according to topline results released Thursday. A pivotal phase 3 trial of ...
Nasdaq

Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first ...

Paris and Tarrytown, N.Y. November 27, 2023. The second Dupixent® (dupilumab) investigational Phase 3 chronic obstructive pulmonary disease (COPD) trial (NOTUS) has shown that Dupixent significantly ...